Since the characterization of the KRAS miRNA-related SNP known as KRAS-LCS6 (rs61764370), there have been a number of studies on the relationship of its genotype with risk 13–18 and prognosis 19–28 of several cancers, with many such studies directed toward colorectal cancer outcome 19–26. Here, KRAS is linked to cancer.